These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 7882365)
21. Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers. Chavany C; Connell Y; Neckers L Mol Pharmacol; 1995 Oct; 48(4):738-46. PubMed ID: 7476902 [TBL] [Abstract][Full Text] [Related]
22. Effects of c-myc oncogene modulation on drug resistance in human small cell lung carcinoma cell lines. Van Waardenburg RC; Prins J; Meijer C; Uges DR; De Vries EG; Mulder NH Anticancer Res; 1996; 16(4A):1963-70. PubMed ID: 8712728 [TBL] [Abstract][Full Text] [Related]
23. Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification. Shivapurkar N; Reddy J; Matta H; Sathyanarayana UG; Huang CX; Toyooka S; Minna JD; Chaudhary PM; Gazdar AF Oncogene; 2002 Dec; 21(55):8510-4. PubMed ID: 12466971 [TBL] [Abstract][Full Text] [Related]
24. Effects of interferon-beta on Daudi cells and on small cell lung carcinoma cells which over-express the c-myc oncogene. Pape KA; Floyd-Smith G Anticancer Res; 1989; 9(6):1737-42. PubMed ID: 2560625 [TBL] [Abstract][Full Text] [Related]
25. Phosphorothioated antisense c-myc oligonucleotide inhibits the growth of human colon carcinoma cells. Yu BW; Nguyen D; Anderson S; Allegra CA Anticancer Res; 1997; 17(6D):4407-13. PubMed ID: 9494542 [TBL] [Abstract][Full Text] [Related]
26. [The effects of RA538 and antisense c-myc on cervical cancer cell lines with high expression of bcl-2 gene]. Chen J; Lin C; Deng Y Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):279-82. PubMed ID: 11778549 [TBL] [Abstract][Full Text] [Related]
27. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux. Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021 [TBL] [Abstract][Full Text] [Related]
28. Reduction of cisplatin cytotoxicity on human lung cancer cell lines with N-myc amplification by pretreatment with N-myc antisense oligodeoxynucleotides. Mizushima Y; Kashii T; Kobayashi M Anticancer Res; 1995; 15(1):37-43. PubMed ID: 7733638 [TBL] [Abstract][Full Text] [Related]
29. Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics. Takahashi T; Obata Y; Sekido Y; Hida T; Ueda R; Watanabe H; Ariyoshi Y; Sugiura T; Takahashi T Cancer Res; 1989 May; 49(10):2683-8. PubMed ID: 2540905 [TBL] [Abstract][Full Text] [Related]
30. Expression of the L-myc gene is under positive control by short-lived proteins. Saksela K Oncogene; 1987; 1(3):291-6. PubMed ID: 2838780 [TBL] [Abstract][Full Text] [Related]
31. Antigenic phenotype and biological characteristics of two distinct sublines derived from a small cell lung carcinoma cell line. Watanabe H; Takahashi T; Ueda R; Utsumi KR; Sato T; Ariyoshi Y; Ota K; Obata Y; Takahashi T Cancer Res; 1988 May; 48(9):2544-9. PubMed ID: 2833350 [TBL] [Abstract][Full Text] [Related]
32. CCKA and CCKB receptors are expressed in small cell lung cancer lines and mediate Ca2+ mobilization and clonal growth. Sethi T; Herget T; Wu SV; Walsh JH; Rozengurt E Cancer Res; 1993 Nov; 53(21):5208-13. PubMed ID: 8221657 [TBL] [Abstract][Full Text] [Related]
34. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells. Abdel-Mageed A; Agrawal KC Cancer Gene Ther; 1997; 4(3):199-207. PubMed ID: 9171939 [TBL] [Abstract][Full Text] [Related]
35. Rearrangement and co-amplification of L-myc and rlf in primary lung cancer. Mäkelä TP; Shiraishi M; Borrello MG; Sekiya T; Alitalo K Oncogene; 1992 Mar; 7(3):405-9. PubMed ID: 1312699 [TBL] [Abstract][Full Text] [Related]
36. Combination of tumor necrosis factor alpha and interferon alpha induces apoptotic cell death through a c-myc-dependent pathway in p53 mutant H226br non-small-cell lung cancer cell line. Yasuoka Y; Naomoto Y; Yamatsuji T; Takaoka M; Kimura M; Uetsuka H; Matsubara N; Fujiwara T; Gunduz M; Tanaka N; Haisa M Exp Cell Res; 2001 Dec; 271(2):214-22. PubMed ID: 11716533 [TBL] [Abstract][Full Text] [Related]
37. Antigene and antiproliferative effects of a c-myc-targeting phosphorothioate triple helix-forming oligonucleotide in human leukemia cells. McGuffie EM; Pacheco D; Carbone GM; Catapano CV Cancer Res; 2000 Jul; 60(14):3790-9. PubMed ID: 10919652 [TBL] [Abstract][Full Text] [Related]
38. A study of myc-related gene expression in small cell lung cancer by in situ hybridization. Gu J; Linnoila RI; Seibel NL; Gazdar AF; Minna JD; Brooks BJ; Hollis GF; Kirsch IR Am J Pathol; 1988 Jul; 132(1):13-7. PubMed ID: 2456019 [TBL] [Abstract][Full Text] [Related]
39. Recombinant antisense C-myc adenovirus increase in vitro sensitivity of osteosarcoma MG-63 cells to cisplatin. Xie XK; Yang DS; Ye ZM; Tao HM Cancer Invest; 2006 Feb; 24(1):1-8. PubMed ID: 16466985 [TBL] [Abstract][Full Text] [Related]
40. [bcl-2 expression in small cell lung cancer: a mechanism for apoptosis antagonism and immune evasion]. Zheng JM; Wang DK; Jiang HM Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec; 25(12):1537-9. PubMed ID: 16361157 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]